Anticancer agent 222
Product Specifications
UNSPSC Description
Anticancer agent 222 (Compound 19) is an orally active anticancer agent that exhibits significant anticancer activity against Huh7, FOCUS, SNU475, SNU182, HepG2, and Hep3B cells (IC50 = 2.9–9.3 μM)[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-222.html
Smiles
FC(F)(F)C(C=C1)=CC=C1C2=NC3=C(N=CN=C3N2C4CCCC4)N(CC5)CCN5C6=CC=C(C(F)(F)F)C=C6
Molecular Weight
560.54
References & Citations
[1]Fatih Polat M, et al. Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells. Bioorg Med Chem Lett. 2024;106:129775.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161648/Anticancer-agent-222-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161648/
Clinical Information
No Development Reported
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6234845-01 0.1 mL
RABEPK (Rab9 Effector Protein with Kelch Motifs, 40kD Rab9 Effector Protein, p40, RAB9P40) (MaxLight 750)
Ask
View Details MBS6234845-02 5x 0.1 mL
RABEPK (Rab9 Effector Protein with Kelch Motifs, 40kD Rab9 Effector Protein, p40, RAB9P40) (MaxLight 750)
Ask
View Details 